TAT-FADD inhibits the initiation of classic NLRP3 inflammasomes and limits the processing and secretion of pro-inflammatory IL-1β, thereby regulating the anti-apoptotic and pro-inflammatory NF-κB signal activation in cancer cells (Ranjan and Waghela, 2020). Here, NFKB1 is linked to cancer.